InsidersTradesSigma
Browse the detailed record of transactions filed by Johan Living, Chief Executive Officer. Officer active across 2 companies, notably Lipigon Pharmaceuticals AB. Cumulatively, 1 disclosures have been recorded. The latest transaction was disclosed on 21 May 2025 — Purchase. Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration
Nikolaj Arrild Sørensen is the Chief Executive Officer of Orexo AB. In this role, he is responsible for the overall management of the company and the implementation of its strategy. Orexo AB is a Swedish company specializing in the development of treatments for addiction disorders. Through his leadership, Nikolaj Arrild Sørensen contributes to the growth and innovation of the company.